CBD is the second most common cannabinoid from the plant of cannabis.


CB1 is the main cannabinoid receptor in the brain but is also found in other tissues. CB1 is a G protein-coupled receptor which inhibits adenylyl cyclase and consequently reduces cAMP upon activation. This in turn regulates many second messenger pathways. 


CBDV is a non-psychoactive cannabinoid with anti-convulsant properties like its homolog CBD. It has also other potential therapeutic properties as antitumorigenic, anti-acne and antiemetic effects.


Tinnitus is described as a sensation of hearing sounds without any external source. This sensation can be similar to hear ringing, clicking, hissing or other sounds.


A Stroke is marked by reduced blood flow to the brain. This reduction can be due to a blocked blood vessle (ischaemia) or a ruptured blood vessle (aneurism). Either way, as a result (part of) the brain is deprived of oxygen and nutrients which in turn causes neuronal degradation and cognitive decline.


There is evidence that cannabis/cannabinoids can be used to treat PTSD and to prevent its development. To date, most evidence points towards THC and CBD and their function to speed up the extinction of fear memories.


Psoriasis is an auto-immune disease characterized by itchy skin lesions. Psoriasis arises when the immune system mistakenly identifies skin cells as foreign matter and causes over-production of new skin cells.


Parkinson's Disease is a degenerative disorder of the nervous system marked by accelerated degeneration of dopamine-producing neurons in the Substantia Nigra in the brain.

Typical symptoms of Parkinson's Disease , such as (intentional) tremor, rigidity and slowness of movement are mostly ascribed to degenerating Substantia Nigra neurons.


pain is a very good target for therapeutic cannabinoids.


OCD is an anxiety disorder characterised by the obsessive urge for repetitive behaviour.